Skip to main content

MEDvidi

Category: AI in Healthcare

An AI-driven telehealth platform specializing in mental healthcare that integrates automated clinical assistants to streamline diagnosis, documentation, and treatment for conditions like ADHD, anxiety, and depression. MEDvidi was founded in 2019. The company is led by Vasili Razhnou. Based in San Jose, USA. Team size: 300+. Total funding raised: $2.8M. Latest round: Seed, $2.8M, 2021-12, led by AltaIR Capital. Key investors include ["AltaIR Capital","TMT Investments","Verras Capital","The Garage Syndicate","Igor Shoifot"].

Founded
2019
Headquarters
San Jose, USA
Team size
300+
Total funding
$2.8M

Value proposition

Combines professional medical expertise with AI automation to reclaim thousands of clinical hours, reducing the impact of the mental health professional shortage while providing affordable, fast-access care.

Products and solutions

["MEDvidi AI Clinical Assistant (Automated documentation & decision support)","Telehealth Consultation Platform","Specialized Treatment Programs (ADHD, Anxiety, Depression, Insomnia)","Online Medication Management & Prescription Services","Personalized Mental Health Dashboards"]

Unique value

Unlike traditional telehealth apps, MEDvidi integrates a proprietary AI Clinical Assistant directly into the workflow to automate the entire clinical encounter, from note-taking to decision support, specifically tailored for mental health nuances.

Target customer

Patients seeking accessible mental health treatment, and healthcare providers/clinicians looking to reduce administrative burnout.

Industries served

["Healthcare","Telemedicine","Mental Health","Artificial Intelligence (HealthTech)"]

Technology advantage

Leverages a hybrid model of 300+ in-house professionals and proprietary AI algorithms to reduce clinical documentation time by up to 50%, significantly increasing patient throughput without compromising care quality.

How they differentiate

Proprietary AI Clinical Assistant integrated into the telehealth workflow that automates documentation and decision support, reducing administrative tasks by up to 50% to combat the clinician shortage.

Main competitors

["Cerebral","Done Health","Talkspace"]

Key partnerships

["Smart IT (Strategic software development partner)","AltaIR Capital (Lead Investor)","TMT Investments (Lead Investor)","Verras Capital","The Garage Syndicate"]

Notable customers

["Direct-to-consumer mental health patients","In-house clinical network of 300+ professionals"]

Major milestones

["Founded in 2019 to provide accessible mental healthcare","Secured $2.8M Seed funding in December 2021","Expanded telehealth operations to cover 20+ US states by 2024","Launched the MEDvidi AI Clinical Assistant in January 2025"]

Growth metrics

Scaled to 300+ employees and expanded clinical services to over 20 US states; AI tools reclaim thousands of clinical hours annually.

Market positioning

Tech-enabled mental health provider specializing in ADHD and anxiety, transitioning from a traditional telehealth model to an AI-first clinical platform.

Geographic focus

United States (currently operating in 20+ states including CA, FL, NY, and TX).

Patents and IP

No registered patents disclosed as of latest update; utilizes proprietary AI models and clinical datasets.

About Vasili Razhnou

Vasili Razhnou is a seasoned entrepreneur with over 15 years of experience in software development and healthcare technology. In 2007, he co-founded Smart IT, a custom software development firm that provided the technical foundation for his later ventures. He has a strong background in scaling telehealth platforms and integrating AI into clinical workflows to improve mental healthcare accessibility.

Official website: